title: Nanotechnology for the Prevention and Treatment of Cataract.
abstract: OBJECTIVE
  The purpose of this article was to review recent advances in the applications of nanotechnology in cataract treatment and prevention strategies.
  
  
  METHODS
  A literature review on the use of nanotechnology for the prevention and treatment of cataract was done.
  
  
  METHODS
  Research articles about nanotechnology-based treatments and prevention technologies for cataract were searched on Web of Science, and the most recent advances were reported.
  
  
  RESULTS
  Nonsteroid anti-inflammatory drugs, natural antioxidants, biologic and chemical chaperones, and chaperones such as molecules have found great application in preventing and treating cataracts. Current scientific research on new treatment strategies, which focuses on the biochemical basis of the disease, will likely result in new anticataract agents. However, none of the drug formulations will be approved for use unless efficient delivery is promised. Nanoparticle engineering together with biomimetic strategies enable the development of next-generation, more efficient, less complex, and personalized treatments.
  
  
  CONCLUSIONS
  The only currently available treatment for cataracts, surgical replacement of the opacified lens, is not an easily accessible option in developing countries. New treatment strategies based on topical drugs would enable treatment to reach massive populations facing the threat of blindness and more effectively deal with the postsurgical complications. Nanotechnology plays a key role in improving drug delivery systems with enhanced controlled release, targeted delivery, and bioavailability to overcome diffusion limitations in the eye.
authors.affiliation: From the *Chemical and Materials Engineering and †Ingenuity Lab, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Sibel
authors.initials: S
authors.lastname: Cetinel
authors.forename: Carlo
authors.initials: C
authors.lastname: Montemagno
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000975:Antioxidants / Q000008:administration & dosage; D001685:Biological Factors / Q000008:administration & dosage; D002386:Cataract / Q000188:drug therapy* / Q000517:prevention & control; D002387:Cataract Extraction / Q000379:methods; D016503:Drug Delivery Systems; D006801:Humans; D018832:Molecular Chaperones / Q000008:administration & dosage; D036103:Nanotechnology / Q000379:methods*; D011183:Postoperative Complications / Q000517:prevention & control
chemical_list: D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D001685:Biological Factors; D018832:Molecular Chaperones